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Abstract
Background
Transgender persons are highly victimized, marginalized, disproportionately experience
incarceration, and have alarmingly increased rates of HIV infection compared to cis-gender
persons. Few studies have examined the HIV care continuum outcomes among transgen-
der women (TW), particularly TW who are involved with the criminal justice (CJ) system.
Methods
To improve our understanding of HIV care continuum outcomes and risk behaviors among
HIV-infected TW who are involved with the CJ system, we analyzed data from the National
Institute on Drug Abuse-supported Seek, Test, Treat, Retain (STTR) Data Harmonization
Initiative. Baseline data were pooled and analyzed from three U.S. STTR studies to examine
HIV risk and care continuum indicators among CJ-involved HIV-infected TW compared to
cisgender men (CM), matched on age (within 5 years) and study at a ratio of 1:5.
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Results
Eighty-eight TW and 440 CM were included in the study. Among matched participants, TW
were more likely to report crack and cocaine use compared to CM (40%,16% respectively,
p<0.001); both TW and CM reported high rates of condomless sex (58%, 64%, respec-
tively); TW were more likely than CM to have more than one sexual partner (OR = 2.9, 95%
CI: 1.6, 5.2; p<0.001) and have engaged in exchange sex (OR = 3.9, 95% CI: 2.3, 6.6;
p<0.001). There were no significant differences between TW and CM in the percentage cur-
rently taking ART (52%, 49%, respectively), the mean percent adherence to ART (77% for
both groups), and the proportion who achieved viral suppression (61%, 58%, respectively).
Conclusions
HIV-infected CJ-involved TW and CM had similar use of ART and viral suppression but TW
were more likely than matched CM to engage in exchange sex, have multiple sexual part-
ners, and use crack/cocaine. TW and CM had similarly high rates of condomless sex and
use of other drugs. TW require tailored risk reduction interventions, however both CJ-
involved TW and CM require focused attention to reduce HIV risk and improve HIV contin-
uum of care outcomes.
Introduction
Transgender persons, defined as those whose current gender identity or expression differs
from their assigned sex at birth [1], are a highly victimized, stigmatized, and socio-economi-
cally marginalized population [2–9]. They experience significant housing instability and twice
the rates of poverty and unemployment compared to the general population of the United
States (US) [8]. Transgender persons disproportionately experience incarceration compared to
cis-gender persons (persons whose gender identity or expression is consistent with their
assigned sex at birth), with 1 in 5 transgender women (TW) reporting at least one previous
incarceration [10, 11]. Transgender individuals are also at extreme risk of HIV infection, with
28% of TW testing positive [12]; a rate 34 times higher than the general US adult population
[13], with alarmingly high rates of infection among Black TW [13, 14].
In general, there is relatively limited data describing HIV-related risk behaviors among
TW. Estimates from one study conducted in Los Angeles County suggested that TW had high
rates of substance use (alcohol, marijuana, and methamphetamines), lifetime injection drug
use, and recent commercial sex work [14]. Another recent study in the San Francisco, CA area
suggested that nearly 32% of TW participants had engaged in condomless receptive anal sex
with a casual partner and 23% with commercial sex partners; and condomless receptive anal
sex with commercial sex partners was more common among HIV-positive participants com-
pared to HIV-negative participants [15].
Despite their marked vulnerability, relatively few studies have examined indicators of
engagement in the HIV care continuum among TW, such as access to antiretroviral treatment
(ART), ART adherence, and HIV viral suppression, and no studies have specifically looked at
these HIV care indicators among TW who are involved in the criminal justice (CJ) system.
This lack of data represents an important knowledge gap given TW are overrepresented in the
criminal justice system, despite comprising a small percentage of the adult U.S. population
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[16]. In addition, while involved in CJ system, TW are often met with unsafe placement,
harassment, assault, and lack of access to health care services [16].
Among studies that have examined HIV care continuum outcomes among TW, results
have been varied and sometimes contradictory [9, 17–21], which may be in part due to hetero-
geneity between study populations and relatively small sample sizes. One study conducted in
Florida suggested that TW enter HIV care later than cisgender women and with more
advanced disease (i.e., diagnosed with AIDS within 3 months of their HIV diagnosis) [17].
Conversely, two multi-site studies conducted in the U.S. found TW had similar levels of HIV
viral suppression when compared to cisgender HIV-infected persons [18, 19]. However, other
studies including both multi-site [9] and single site studies conducted in California [20, 21]
have found that TW are less likely to achieve viral suppression. Beyond the HIV care contin-
uum, there appear to be disparities related to the quality of HIV care; a large US study found
HIV-infected TW reported significantly fewer positive interactions with their healthcare pro-
viders compared to cisgender persons [22].
There is a clear and consistent link between social and economic marginalization, violent
and sexual victimization, and HIV treatment outcomes among TW [23]. A recent study found
housing instability to be associated with poor HIV treatment outcomes among TW [21]. Struc-
tural barriers, such as lack of employment and decreased access to food or housing, have also
been associated with condomless anal sex and increased victimization among HIV-negative
TW [24]. A global meta-analysis found that TW required more intensive supportive services
and higher percentages of TW needed basic services such as food and housing assistance com-
pared to HIV-infected cisgender persons [8].
To improve our understanding of HIV care continuum outcomes and risk behaviors
among HIV-infected TW who are involved with the CJ system, we analyzed data from the
multi-study National Institute on Drug Abuse-supported Seek, Test, Treat, Retain (STTR)
Data Harmonization Initiative. HIV risk and care continuum indicators among CJ-involved
HIV-infected TW were compared to CJ-involved HIV-infected CM.
Materials and methods
Data for these analyses were collected from three separate studies within the STTR consortium
(https://sttr-hiv.org/). The consortium’s goal is to integrate data from multiple studies to
address research questions related to HIV care continuum outcomes among vulnerable popu-
lations that require larger sample sizes than the individual studies provided [25]. The consor-
tium has harmonized data from numerous independent STTR research studies on multiple
domains including: demographic information, substance use, criminal justice (CJ) status, ART
adherence, HIV risk behaviors (e.g., condomless sex, injection drug use), and HIV care contin-
uum outcomes including HIV viral suppression defined as an HIV viral load (VL) of 200
copies/ml. To conduct these analyses, data were pooled from three STTR studies (Table 1) that
met the following criteria:1) enrolled a minimum of five HIV-infected TW; 2) enrolled HIV-
infected CM; 3) collected data on the majority of the domains of interest at the study baseline
assessment, and 4) were conducted in the US. All three of the studies focused specifically on
CJ-involved participants, including two studies that recruited participants in CJ-based settings
(prisons, jails, detention centers, and persons under community supervision, e.g. probation or
parole status), and one study that recruited participants after release from jail.
Herein, we briefly summarize the study populations and sites of recruitment. The LINK LA
Study and CARE+ Corrections studies have been described in detail elsewhere [26, 27]. The
LINK LA study recruited HIV-infected men and TW who were incarcerated in the LA County
jail system and who were referred to the transitional case management program. Participants
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were 18 years of age or older, English or Spanish speaking, and eligible for ART. LINK LA
enrolled 356 participants from 2012–2016. The CARE+ Corrections study recruited HIV-
infected persons who were 18 years or age or older, English speaking, and who were incarcer-
ated in Washington D.C. Department of Corrections facilities or recently incarcerated (within
the previous six months). CARE+ Corrections enrolled 112 participants between 2013–2015.
The STT Jail study recruited HIV-infected persons who were 18 years of age or older, English-
speaking, and who were anticipated to be released from the Cook County Jail within six
months. STT Jail enrolled 460 participants between 2013–2016.
Information on age, race and ethnicity, education, homelessness, health insurance, ART
adherence measured though the Visual Analogue Scale (VAS) [28], and use of alcohol and
illicit drugs was collected during the baseline assessments for each study. Except for age, race
and ethnicity, and education, participants were asked to report risk behaviors and engagement
in HIV treatment during a specific reference period which varied by study and in some cases
by behavior within study (i.e., 30, 90, or 180 days prior to incarceration for current detainees
or those recently released from incarceration). In studies where the baseline survey was admin-
istered in the community, CJ supervision status was collected by self-report or from CJ admin-
istrative records. Risk behavior questionnaires elicited information regarding participants’
sexual and drug using risk behaviors during each study’s reference period. Specifically, partici-
pants were asked about their engagement in vaginal or anal intercourse, condom use, number
of sexual partners, and exchange sex (defined as having sex to receive money, alcohol, drugs,
or other things). Participants were asked about any use of alcohol, binge alcohol, marijuana,
crack/cocaine, opioids, stimulants, other substances, multiple substances; hazardous drinking
was assessed using the AUDIT-C [29]. HIV VL was assessed through laboratory testing per-
formed by the study or review of recent medical records.
Using a risk set sampling approach, all eligible TW from the three studies were selected and
matched at a ratio of 1:5 to CM participants on age (within 5 years) and study. While each of
the five CM participants matched to a TW participant were unique individuals, CM partici-
pants were eligible to be randomly sampled as controls for multiple TW for whom they met
the matching criteria. A total of 88 TW and 440 CM were included in the study. Conditional
logistic regression was used to test for differences between matched TW and CM participants
in risk behaviors and HIV care outcomes represented as binary variables. Differences in char-
acteristics represented as continuous variables were tested using generalized linear models
with robust standard errors. P-values < 0.05 were considered statistically significant.
Table 1. Participating studies, enrolled populations, study site, number of transgender women study participants.
Study Enrolled Population Study Site Transgender women
(#)
Transgender definition
LINK LA1 HIV-infected persons leaving
correctional facilities
Los Angeles, CA 52 Self-report of TG or reported gender differed from reported
sex assignment at birth.
CARE
+ Corrections 2
HIV-infected persons in jail or recently
released from jail
Washington, D.
C.
20 Self-report of TG or reported gender differed from reported
sex assignment at birth.
STT Jail 3 HIV-infected persons leaving
correctional facilities
Chicago, IL 16 Self-report of TG
1 Effectiveness of Peer Navigation to Link Released HIV+ Jail Inmates to HIV Care (LINK LA).
2 CARE+ Corrections: Technology for Jail HIV/HCV Testing, Linkage, and Care (CARE+ Corrections).
3 Seek, Test, Treat: An Integrated Jail-Prison-Community Model for Illinois (STT Jail).
https://doi.org/10.1371/journal.pone.0197730.t001
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The studies were approved by the following institutional review boards: The University of
California, Los Angeles (LINK LA), Los Angeles County Department of Public Health (LINK
LA), George Washington University (CARE+ Corrections), The Miriam Hospital (CARE
+ Corrections), University of Illinois at Chicago (STT Jail), and the Cook County Health and
Hospitals System (STT Jail). Additional protections were provided by the Office of Human
Research Protections at the Department of Health and Human Services, and Certificates of
Confidentiality were obtained.
Results
Table 2 displays demographic characteristics of study participants, stratified by study and gen-
der. Overall, the mean age across groups was 35 years (±10), 53% were Black, and 23% were
Hispanic. A slightly higher proportion of TW reported being homeless compared to CM (49%
and 41% respectively), while similar proportions of TW (43%) and CM (39%) reported not
having health insurance.
As outlined in Table 3, any alcohol use and binge drinking were common across all studies
and groups, with more than one-half of all respondents reporting any alcohol use. Across indi-
vidual studies, between 25% and 69% reported binge drinking. From the two studies that mea-
sured hazardous drinking, the overall proportion of TW and CM participants classified as
hazardous drinkers was 42% and 40%, respectively. Overall, marijuana and stimulant use was
common, although the range of use of these substances varied greatly across studies. For crack
and cocaine use, the proportion of use also varied across studies, but overall, TW were more
likely to report crack and cocaine use compared to CM (40% and 16% respectively, p<0.001).
Opioid use across all studies and among TW and CM was relatively low compared to the other
substances (13% and 15%, respectively). TW were more likely than CM to use multiple sub-
stances defined as using 2 substances (including alcohol) (74% and 62% respectively, p = 0.04).
Table 4 displays sexual risk behaviors reported by study participants. Both TW and CM
reported high rates of condomless sex (58% and 64%, respectively; p = 0.37). TW were signifi-
cantly more likely than CM to have more than one sexual partner (OR = 2.9, 95% CI: 1.6, 5.2;
p<0.001) and have engaged in exchange sex (OR = 3.9, 95% CI: 2.3, 6.6; p<0.001).
Table 5 displays HIV care continuum outcomes reported by study participants. Overall,
there was no significant difference between TW and CM in the percentage currently taking
ART, with 52% of TW and 49% of CM on ART (OR = 1.1; 95% CI: 0.7–1.8, p = 0.6). Similarly,
there were no significant differences between TW and CM in the mean percent adherence to
ART (77% for both groups), the proportion who achieved viral suppression (61% and 58%,
respectively), or the proportion who had CD4 counts 200 compared to CM (OR = 0.4; 95%
CI: 0.1–2.1, p = 0.30).
Discussion
This study among HIV-infected persons in the CJ system found no significant difference
between TW and CM in the use of ART, reported adherence to ART, or with achieving viral
suppression. Approximately one-half of our study population reported being on ART at the
time of baseline data collection and close to 60% were found to have viral suppression. The pro-
portion receiving ART was similar to the results among jailed persons in a recent systematic
review that indicated 51% of persons were on ART during incarceration which decreased to
29% after release, and 40% achieved viral suppression during incarceration which decreased to
21% after release [30]. One explanation for our findings may be that both TW and CM were bet-
ter able to access HIV care and treatment during periods of incarceration compared to when
residing in the community, thus attenuating any potential differences that may exist outside of
Risk behaviors and HIV care continuum outcomes among HIV-infected transgender women and cisgender men
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the correctional setting. We were not able to assess changes in ART use or viral suppression fol-
lowing release from correctional facilities in this study, but other studies have demonstrated
decreased ART use and consequent viral rebound during community re-entry [30–33].
In our study, TW were more likely to engage in several HIV transmission behaviors com-
pared to age-matched CM from the same studies. While both TW and CM reported high rates
of condomless sex, TW were more likely than CM to have multiple sexual partners and to
engage in exchange sex. Similarly, high rates of substance use were reported among both TW
and CM, but the proportion of TW using crack/cocaine was more than twice as high as that of
CM. Despite TW reporting higher rates of engagement in HIV transmission behaviors, both
populations had similarly sub-optimal HIV continuum of care outcomes including ART use,
ART adherence, and viral suppression. These findings suggest that interventions to improve
HIV care engagement and viral suppression in both TW and CM are needed, but that TW
would especially benefit from gender-tailored interventions that address their unique vulnera-
bilities and risk behaviors.
In both TW and CM, rates of condom use and ART were low while rates of substance use
were high. Substance use disorders have been linked to both high risk HIV transmission
behaviors and poor retention in HIV care [34, 35], including among TW [36, 37]. The sub-
optimal outcomes in this sample of CJ-involved TW and CM are particularly concerning
Table 2. Demographic characteristics of study participants, comparing transgender women and cisgender men.
STTR Study
LINK LA CARE + Corrections STT Jail Total
Los Angeles, CA Washington D.C. Chicago, IL
TW CM TW CM TW CM TW CM
N 52 260 20 100 16 80 88 440
Age, years 36 ± 10 36 ± 10 35 ± 9 34 ± 10 32 ± 11 33 ± 11 35 ± 10 35 ± 10
Age, years 36 ± 10 34 ± 10 32 ± 11 35 ± 10
Race/ Ethnicity (%)
Black 38 30 85 91 94 75 59 52
Hispanic 35 35 0 1 6 14 22 23
White 4 25 5 3 0 9 3 17
Other1 23 10 10 5 0 2 16 8
Education (%)
< High School 52 40 35 26 31 40 44 37
High school 13 16 45 56 38 33 25 28
>High school 35 43 20 18 31 27 31 34
Unknown 0 1 0 0 0 0 0 1
Homeless (%)
No 31 45 — — 56 50 372 462
Yes 69 55 — — 44 50 632 542
Not collected 0 0 100 100 0 0 — —
Health Insurance (%)
Uninsured 60 50 20 10 19 37 43 39
Insured 38 48 80 90 69 58 54 59
Unknown 2 2 0 0 12 5 3 2
1Includes participants reporting race as Asian, Native American/Alaskan Native, Pacific Islander, having 2 or more races.
2Percentages are calculated as percent of total individuals with data collected.
Abbreviations: TW-transgender women; CM-cisgender males.
https://doi.org/10.1371/journal.pone.0197730.t002
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given that incarceration is often viewed as an opportunity to re-engage people living with HIV
in care [38, 39]. These findings speak to the need for innovative methods that support reten-
tion in HIV care and HIV prevention efforts, including the expansion of case management ser-
vices, ART adherence counseling, and comprehensive substance abuse treatment services.
Table 3. Substance use during reference period1, comparing transgender women and cisgender men.
Los Angeles Washington D.C. Chicago Total p-value
TW CM TW CM TW CM TW CM
N 52 260 20 100 16 80 88 440
Any use (%)
Alcohol 65 51 75 80 81 70 71 61 0.1
Binge Alcohol 31 25 55 58 69 41 43 35 0.1
Marijuana 46 62 40 32 81 53 51 53 0.7
Crack/ cocaine 33 10 45 22 56 31 40 16 <0.001
Opioids 14 12 5 16 19 25 13 15 0.5
Stimulants 58 67 20 4 31 16 44 44 0.9
Other Substance 4 9 25 13 25 15 13 11 0.7
Multiple Substances2 77 68 55 46 88 64 74 62 0.04
No Substances 10 12 0 15 0 15 6 13 0.06
Hazardous Drinking
AUDIT-C score — — 4.0 ± 4.1 5.0 ± 4.2 5.8 ± 4.4 3.6 ± 4.0 4.8 ± 4.3 4.4 ± 4.2 0.6
AUDIT-C category (%)
Non-drinker — — 25 20 19 35 223 273
Non-hazardous drinker — — 45 33 25 33 363 333
Hazardous drinker — — 30 47 56 32 423 403 0.84
1Alcohol reference periods differed across studies: 30 days: LINK LA; 180 days: STT Jail; 1 year: CARE+ Corrections.
Illicit substance reference periods differed across studies: 30 days: LINK LA; 90 days: CARE+ Corrections; 180 days: STT Illinois.
2 Multiple substance use was defined as using 2 substances (including alcohol).
3 Percentages are calculated as percent of total individuals with data collected.
Abbreviations: TW-transgender women; CM-cisgender males.
https://doi.org/10.1371/journal.pone.0197730.t003
Table 4. HIV risk behaviors during reference period1, comparing transgender women and cisgender men.
Los Angeles Washington D.C. Chicago Total OR
(95% CI)
p-value
TW CM TW CM TW CM TW CM
N 52 260 20 100 16 80 88 440
>1 sex partner (%) 45 24 — — 67 36 482 262 2.9 (1.6–5.2) <0.001
Condomless sex (%) 54 63 78 82 44 39 583 643 0.8 (0.5–1.3) 0.37
Exchange sex (%) 46 22 65 15 — — 514 204 3.9 (2.3–6.6) <0.001
1Reference periods differed across studies: 90 days: CARE+ Corrections, STT Jail; 180 days: LINK LA.
2Refused and “Don’t know” responses were set to missing (LINK LA TW: n = 1; STT Jail TW: n = 1; STT Jail CM: n = 1); percentages are calculated as percent of total
non-missing responses.
3Refused and “Don’t know” responses were set to missing (LINK LA TW: n = 2; LINK LA CM: n = 17; STT Jail TW: n = 1, STT Jail CM: n = 3); percentages are
calculated as percent of total non-missing responses.
4 Percentages are calculated as percent of total individuals with data collected.
Abbreviations: TW-transgender women; CM-cisgender males; OR-odds ratio; CI-confidence interval.
https://doi.org/10.1371/journal.pone.0197730.t004
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The TW in this study were uniquely vulnerable due to higher rates of crack/cocaine use
than CM. There are no approved pharmacotherapies for cocaine use disorders; cognitive
behavioral therapy is currently the only approved management option and is often unavailable
to socially disenfranchised populations such as TW. In addition, high rates of exchange sex
and cocaine use in TW may be intertwined, where TW may be more likely to find themselves
needing to engage in exchange sex to support their addiction. Approximately 40% of TW and
CM in this study reported stimulant use. Previously published studies of female sex workers
and men who have sex with men (MSM) have revealed patterns of stimulant use during sexual
encounters were attributed to a number of factors, including sexual enhancement, increased
energy levels, and as a coping mechanism during exchange sex [40, 41]. To reduce risk behav-
iors and improve HIV continuum of care outcomes among TW and CM, new approaches to
treat cocaine and stimulant use disorders are needed and the development of new behavioral
and pharmacological interventions must be a research priority. Importantly, TW require sub-
stance abuse treatment programs that are non-judgmental, inclusive of their gender and sexual
orientation, and that address other co-occurring needs such as lack of social support, stigma,
and frequent history of abuse and harassment [42].
The differences in sexual risk behaviors and substance use patterns between TW and CM
suggest that there may be opportunities to reduce transmission of HIV and improve treatment
outcomes through gender-tailored interventions [43]. While condom use was similar between
populations (36–42%), TW were more likely to have multiple sexual partners, which creates a
higher risk of HIV transmission when only 42% of HIV-infected TW reported consistently
using condoms. Thus, it is particularly important to prioritize interventions that can improve
condom use as well as optimize ART adherence and viral suppression in TW [44]. Relatedly,
TW were almost 4 times more likely to engage in exchange sex. TW have historically been
socially marginalized and stigmatized in ways that may increase their likelihood of engaging in
commercial sex work [7, 23, 45]. While TW appear to be accessing HIV care at rates similar to
CM, their engagement in exchange sex indicates a social vulnerability that can influence their
continued access to care and ability to negotiate condom use [23, 46]. Future interventions tar-
geting TW should acknowledge the contextual factors relevant to TW that can affect HIV risk
behavior such as gender-based power imbalances, stigma, increased risk of interpersonal or
Table 5. HIV care continuum outcomes during reference period1, comparing transgender women and cisgender men.
Los Angeles Washington D.C. Chicago Total OR/β
(95% CI)
p-value
TW CM TW CM TW CM TW CM
N 52 260 20 100 16 80 88 440
Current ART (%) 40 47 70 47 69 57 52 49 OR = 1.1 (0.7–1.8) 0.57
% ART adherence 67 ± 32 79 ± 27 90 ± 18 70 ± 25
— —
77 ± 29 77 ± 27 β = 0.3 (-10.5–11.1) 0.96
VL2 200
copies/ml (%)
56 62 80 57 50 39 613 583 OR = 1.1 (0.7–1.9) 0.61
CD4+ cell count2 200 (%) — — 5 9 10 25 7 15 OR = 0.4 (0.1–2.1) 0.30
1ART reference periods differed across studies: CARE+ Corrections, LINK LA: 30 days prior to incarceration; STT Jail (taking ART only): 7 days prior to arrest.
2VL and CD4 measurements were from within 30 days of baseline interview.
3Viral load measures were missing on some participants (CARE+ Corrections CM n = 3; LINK LA CM: n = 8; STT Jail TW: n = 6; STT Jail CM: n = 28); percentages are
calculated as percent of total non-missing responses.
Abbreviations: TW-transgender women; CM-cisgender males; OR-odds ratio; β-beta; CI-confidence interval; ART-antiretroviral treatment; VL-viral load; ml-milliliter.
https://doi.org/10.1371/journal.pone.0197730.t005
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sexual violence, financial vulnerability, and the work environment (e.g. public vs. indoor)
when engaging in exchange sex [47–52].
There were limitations to this study. Two of the three STTR studies included recruited per-
sons inside correctional facilities, which may have influenced HIV treatment outcomes since
these persons may have better access to HIV treatment than persons enrolled in the commu-
nity. This study was a secondary analysis of cross-sectional data collected through the STTR
consortium, hence, the three studies included were heterogeneous in terms of study design, eli-
gibility criteria, geographic location, and the reference periods used for assessing baseline sub-
stance use and sexual risk behaviors. While this may limit the robustness of our findings, the
geographic heterogeneity provided a more nationally representative sample than single-site
studies. Furthermore, the use of matching in the analysis ensured that comparisons were made
between TW and CM within the same study, thus between-study differences cannot account
for the observed differences between TW and CM risk behaviors. Including cisgender women
as a comparison group in the analysis would have enhanced the study, but not all of the studies
included in this analysis recruited cisgender women. Similarly, not all of the studies collected
information on sexual orientation, thus we were unable to identify MSM. If the majority of
CM in this study were MSM, a group that also experiences high rates of stigma and substance
use, this may have attenuated differences between the TW and CM than may have been
observed if the TW were compared to non-MSM HIV-infected men.
In conclusion, we found that CJ-involved HIV-infected TW, as compared to CJ-involved
HIV-infected CM, had similar HIV continuum of care outcomes but TW were more likely to
engage in exchange sex, have multiple sexual partners, and use crack/cocaine or multiple sub-
stances. Nevertheless, TW and CM had similarly high rates of condomless sex and use of illicit
drugs and other substances. These results indicate that TW require population-specific inter-
ventions that address specific HIV transmission behaviors and are also sensitive to the unique
barriers to care and psychosocial vulnerabilities that many TW experience. In general, though,
interventions are needed for both CM and TW that target condomless sex, substance use
behaviors, and engagement in HIV care to improve HIV-related outcomes.
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